Immunotheranostics: Breaking tolerance in immunotherapy using tumor autoantigens identified on protein microarrays

Current Opinion in Drug Discovery and Development

Volumn 9, Issue 3, 2006, Pages 380-385

  Chatterjee, Madhumita ^a   Draghici, Sorin ^a,b   Tainsky, Michael A ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Wayne State University   (United States)

Author keywords

Bioinformatics; Epitomics; Personalized immunotherapy; Tumor antigen microarrays

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; CANCER TESTIS ANTIGEN; CANCER VACCINE; CARBONIC ANHYDRASE XII; ECALECTIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; INITIATION FACTOR 4G; LAGE1 ANTIGEN; MELANOCYTE SPECIFIC PROTEIN TYROSINASE; NY BR 1 ANTIGEN; NY CO 27 ANTIGEN; PROTEIN P53; RAB38 ANTIGEN; RECOMBINANT INTERLEUKIN 2; SSX2 ANTIGEN; TUMOR ANTIGEN; UNCLASSIFIED DRUG; VIRUS ANTIGEN; XAGE1 ANTIGEN;

ANTIGEN BINDING; BIOINFORMATICS; BIOSENSOR; CANCER; CELLULAR IMMUNITY; CLINICAL TRIAL; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMORAL IMMUNITY; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; KIDNEY CARCINOMA; MELANOMA; PROSTATE CANCER; PROTEIN MICROARRAY; REVIEW; SERODIAGNOSIS;

ANIMALS; ANTIGENS, NEOPLASM; AUTOANTIGENS; HUMANS; IMMUNE TOLERANCE; IMMUNOTHERAPY; NEOPLASMS; PROTEIN ARRAY ANALYSIS;

EID: 33646852824     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Draghici S, Chatterjee M, Tainsky MA: Epitomics: Serum screening for the early detection of cancer on microarrays using complex panels of tumor antigens. Expert Rev Mol Diagnostics (2005) 5(5)735-743. Describes a novel cloning and bioinformatics analytical technology comprising panels of tumor antigens on protein microarrays.
2. Chatterjee M, Mohapatra S, Wang X, Nowak J, Nahhas AF, Lu K, Witkin SS, Fishman D, Munkarah A, Morris R, Levin KN et al: Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays. Cancer Res (2006) 66(2):1181-90.
3. Sahin U, Tureci O, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I, Pfreundschuh M: Human neoplasms elicit multiple specific Immune responses in the autologous host Proc Natl Acad Sci USA (1995) 92(25):11810-11813. Describes the development of a systematic tumor antigen cloning technology.
4. Scanlan MJ, Gure AO, Jungbluth AA, Old LJ, Chen YT: Cancer/testis antigens: An expanding family of targets for cancer immunotherapy. Immunol Rev (2002) 188:22-32.
5. Scanlan MJ, Simpson AJ, Old LJ: The cancer/testis genes: Review, standardization, and commentary. Cancer Immunity (2004) 4:1. www.cancerimmunity.org/v4p1/031220.htm
6. Crew AJ, Clark J, Fisher C, Gill S, Grimer R, Chand A, Shipley J, Gusterson BA, Cooper CS: Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma. EMBO J (1995) 14(10):2333-2340.
7. Chen YT, Scanlan MJ, Sahin U, Tureci O, Gure AO, Tsang S, Wlliamson B, Stockert E, Pfreundschuh M, Old LJ: A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA (1997) 94(5):1914-1918
8. Lethe B, Lucas S, Michaux L, De Smet C, Godelaine D, Serrano A, De Plaen E. Boon T: LAGE-1, a new gene with tumor specificity. Int J Cancer 1998, 76(6):903-908.
9. Boon T, van der Bruggen P: Human tumor antigens recognized by T lymphocytes. J Exp Med (1996) 183(3):725-729.
10. Chen YT, Scanlan MJ, Sahin U, Tureci O, Gure AO, Tsang S, Wlliamson B, Stockert E, Pfreundschuh M, Old U: A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA (1997) 94(5):1914-1918.
11. Chen YT, Gure AO, Tsang S, Stockert E, Jager E, Knuth A, Old LJ: Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library. Proc Natl Acad Sci USA (1998) 95(12):6919-6923.
12. Jager D, Stockert E, Scanlan MJ, Gure AO, Jager E, Knuth A, Old LJ, Chen YT: Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: Characterization of tissue-specific ING1 transcripts and a homologue gene. Cancer Res (1999) 59(24):6197-6204.
13. Scanlan MJ, Gout I, Gordon CM, Williamson B, Stockert E, Gure AO, Jager D, Chen YT, Mackay A, O'Hare MJ, Old U: Humoral Immunity to human breast cancer: Antigen definition and quantitative analysis of mRNA expression. Cancer Immunity (2001) 1:4. www.cancerimmunity.orgA/1p4/010202.htm
14. Stone B, Schummer M, Paley PJ, Thompson L, Stewart J, Ford M, Crawford M, Urban N, O'Briant K, Nelson BH: Serologic analysis of ovarian tumor antigens reveals a bias toward antigens encoded on 17q. Int J Cancer (2003) 104(1):73-84.
15. Ehlken H, Schadendorf D, Eichmuller S: Humoral immune response against melanoma antigens induced by vaccination with cytokine gene-modified autologous tumor cells. Int J Cancer (2004) 108(2):307-313.
16. Jager D, Unkelbach M, Frei C, Bert F, Scanlan MJ, Jager E, Old LJ, Chen YT, Knuth A: Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum. Cancer Immunity (2002) 2:5. www.cancerimmunity.org/v2p5/020605.htm
17. Cho B, Lim Y, Lee DY, Park SY, Lee H, Kim VW, Yang H, Bang YJ, Jeoung DI: Identification and characterization of a novel cancer/testis antigen gene CAGE. Biochem Biophys Res Commun (2002) 292(3):715-726.
18. Eichmuller S, Usener D, Dummer R, Stein A, Thiel D, Schadendorf D: Serological detection of cutaneous T-cell lymphoma-associated antigens. Proc Natl Acad Sci USA (2001) 98(2):629-634.
19. Ali Eldib AM, Ono T, Shimono M, Kaneko M, Nakagawa K, Tanaka R, Noguchi Y, Nakayama E: Immunoscreening of a cDNA library from a lung cancer cell line using autologous patient serum: Identification of XAGE-1b as a dominant antigen and its immunogenicity in lung adenocarcinoma. Int J Cancer (2004) 108(4):558-563.
20. Scanlan MJ, Chen YT, Williamson B, Gure AO, Stockert E, Gordan JD, Tureci O, Sahin U, Pfreundschuh M, Old LJ: Characterization of human colon cancer antigens recognized by autologous antibodies. Int J Cancer (1998) 76(5):652-658.
21. Line A, Slucka Z, Stengrevics A, Silina K, Li G, Rees RC: Characterisation of tumour-associated antigens in colon cancer. Cancer Immunol Immunother (2002) 51(10):574-582.
22. Ishikawa T, Fujita T, Suzuki Y, Okabe S, Yuasa Y, Iwai T, Kawakami Y: Tumor-specific immunological recognition of frameshift-mutated peptides in colon cancer with microsatellite instability. Cancer Res (2003) 63(17):5564-5572.
23. Obata Y, Takahashi T, Sakamoto J, Tamaki H, Tominaga S, Hamajima N, Chen YT, Old LJ: SEREX analysis of gastric cancer antigens. Cancer Chemother Pharmacol (2000) 46(Suppl):S37-S42.
24. Jager D, Stockert E, Gure AO, Scanlan MJ, Karbach J, Jager E, Knuth A, Old LJ, Chen YT: Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library. Cancer Res (2001) 61(5):2055-2061.
25. Jager D, Stockert E, Jager E, Gure AO, Scanlan MJ, Knuth A, Old LJ, Chen YT: Serological cloning of a melanocyte rab guanosine 5′-triphosphate- binding protein and a chromosome condensation protein from a melanoma complementary DNA library. Cancer Res (2000) 60(13):3584-3591.
26. Tureci O, Sahin U, Vollmar E, Siemer S, Gottert E, Seite G, Parkkila AK, Shah GN, Grubb JH, Pfreundschuh M, Sly WS: Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers. Proc Natl Acad Sci USA (1998) 95(13)7608-7613.
27. Tureci O, Schnitt H, Fadle N, Pfreundschuh M, Sahin U: Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkin's disease. J Biol Chem (1997) 272(10):6416-6422.
28. Brass N, Heckel D, Sahin U, Pfreundschuh M, Sybrecht GW, Meese E: Translation initiation factor eIF-4γ is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma. Hum Mol Genet (1997) 6(1):33-39.
29. Scanlan MJ, Williamson B, Jungbluth A, Stockert E, Arden KC, Viars CS, Gure AO, Gordan JD, Chen YT, Old U: Isoforms of the human PDZ-73 protein exhibit differential tissue expression. Biochim Biophys Acta (1999) 1446(1):39-52.
30. Herrmann M, Hagenhofer M, Kalden JR: Retroviruses and systemic lupus erythematosus. Immunol Rev (1996) 152:145-156.
31. Walchner M, Leib-Mosch C, Messer G, Germaier H, Plewig G, Kind P: Endogenous retroviral sequences in the pathogenesis of systemic autoimmune disease. Arch Dermatol (1997) 133(6):767-771.
32. Herbst H, Sauter M, Mueller-Lantzsch N: Expression of human endogenous retrovirus K elements in germ cell and trophoblastic tumors. Am J Pathol (1996) 149(5):1727-1735.
33. Pepe MS, Longton G, Anderson GL, Schummer M: Selecting differentially expressed genes from microarray experiments. Biometrics (2003) 59(1):133-142. This reference, along with reference [34.], describes statistical methods for the identification of significant biomarkers.
34. Dodd LE, Pepe MS: Partial AUC estimation and regression. Biometrics (2003) 59(3):614-623. This reference, along with reference [33•], describes statistical methods for the identification of significant biomarkers.
35. Modak S, Gerald W, Cheung NK: Disialoganglioside GD2 and a novel tumor antigen: Potential targets for immunotherapy of desmoplastic small round cell tumor. Med Pediatr Oncol (2002) 39(6):547-551.
36. Nestle FO, Banchereau J, Hart D: Dendritic cells: On the move from bench to bedside. Nat Med (2001) 7(7):761-765. Describes the application of immunostimulatory DC-based vaccination in immunotherapy.
37. Breckpot K, Heirman C, Neyns B, Thielemans K: Exploiting dendritic cells for cancer immunotherapy: Genetic modification of dendritic cells. J Gene Med (2004) 6(11 ):1175-1188.
38. Belldegrun A, Shvarts O, Figlin RA: Expanding the indications for surgery and adjuvant interleukin-2-based immunotherapy in patients with advanced renal cell carcinoma. Cancer J Sci Am (2000) 6(Suppl 1):S88-S92.
39. Soiffer R, Lynch T, Mihm M, Jung K, Rhuda C, Schmollinger JC, Hodi FS, Liebster L, Lam P, Mentzer S, Singer S et al: Vaccination with Irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma. Proc Natl Acad Sci USA (1998) 95(22):13141-13146.
40. Simons JW, Mikhak B, Chang JF, DeMarzo AM, Carducci MA, Lim M, Weber CE, Baccala AA, Goemann MA, Clift SM, Ando DG et al: Induction of immunity to prostate cancer antigens: Results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer. Cancer Res (1999) 59(20):5160-5168.
41. Abken H, Hombach A, Heuser C, Kronfeld K, Seliger B: Tuning tumor-specific T-cell activation: A matter of costimulation? Trends Immunol (2002) 23(5):240-245. Reviews the reasons behind the need for immunomodulators that provide an effective antitumor cytotoxic T-lymphocyte response.
42. Jager E, Ringhoffer M, Karbach J, Arand M, Oesch F, Knuth A: Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic-T-cell responses: Evidence for immunoselection of antigen-loss variants in vivo. Int J Cancer (1996) 66(4):470-476. Describes how differentiation antigens mediate the regression of antigen-positive tumors, and how tolerance may occur as a result of variants that have lost the ability to express antigens.
43. Wolfram RM, Budinsky AC, Brodowicz T, Kubista M, Kostler WJ, Kichler-Lakomy C, Hellan M, Kahlhammer G, Wiltschke C, Zielinski CC: Defective antigen presentation resulting from impaired expression of costimulatory molecules in breast cancer. Int J Cancer (2000) 88(2):239-244.
44. Seliger B, Maeurer MJ, Ferrone S: TAP off - tumors on. Immunol Today (1997) 18(6):292-299.
45. Wojtowicz-Praga S: Reversal of tumor-induced immunosuppression: A new approach to cancer therapy. J Immunother (1997) 20(3):165-177.
46. Nowak JE, Chatterjee M, Dryden SC, Mohapatra S, Tainsky MA: Direct production and purification of T7 phage display cloned proteins selected and analyzed on microarrays. BioTechniques (2006) 40(2):220-227.
47. Keilholz U, Weber J, Finke JH, Gabrilovich DI, Kast WM, Disis ML, Kirkwood JM, Scheibenbogen C, Schlom J, Malno VC, Lyerly HK et al: Immunologic monitoring of cancer vaccine therapy: Results of a workshop sponsored by the Society for Biological Therapy. J Immunother (2002) 25(2):97-138. Provides an excellent review of the state-of-the-art in immunomonitoring of immunotherapy trials.